Private equity investment in various sub-specialties, such as retina and oral surgery, continues to be a significant trend, providing even more opportunities for private equity to invest in the healthcare space. Experts spoke on a panel titled “Advanced PPM Topics: The Evolution of Sub-Specialty Investment Strategies” at the 17th Annual Healthcare and Life Sciences Private Equity & Finance Conference, held in Chicago on February19 and 20, 2020. Experts included Giovanni Barbat, President at American Vision Group; Roy Berjano, Co-Founder and CEO at Scale Physician Group; Richard Hall, President and CEO at US Oral Surgery Management; Todd Roland, Principal at GCM Grosvenor; and Timothy Wentink, Managing Director at Twin Brook Capital Partners. The panel was moderated by Tim Fry, an attorney in the Chicago office of McGuireWoods LLP. Here are five key takeaways from the panel discussion.
Read the full article: The Evolution of Sub-Specialty Investment Strategies: Five Takeaways //
Source: https://www.lexology.com/library/detail.aspx?g=8eb1f34f-a03b-44f9-a227-741773917195